Class Members Eligible for Disposable Hypodermic Products Antitrust Settlement:
The indirect settlement class consists of all persons or entities (or assignees of claims from such persons and entities) who purchased BD Disposable Hypodermic Products through a distributor or wholesaler or any other third party other than BD at any time during the Class Period defined as January 1, 1988 through July 30, 2013. All persons are entities must have purchased in the following states: Alabama, Arizona, California, District of Columbia, Florida, Hawaii, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Montana, Nebraska, Nevada, New Mexico, New York, North Carolina, North Dakota, South Carolina, South Dakota, Tennessee, Utah, Vermont, West Virginia and Wisconsin. If you fall within these class qualifications then can be eligible for the Hypodermic Products Antitrust Settlement.
Class Action Claims Recovery is here to determine your verification status and file on your behalf, so you may recover proper damages from the Disposable Hypodermic Products Antitrust Settlement.
Disposable Hypodermic Products Antitrust Settlement Case History:
The Court has preliminarily approved a proposed $22 million Hypodermic Products Antitrust Settlement in a class action lawsuit, which claims that BD violated federal antitrust laws with respect to the sale of BD Hypodermic Products. The Lawsuit claims that BD engaged in several forms of anticompetitive practices including (1) imposing market share purchase requirements on hospitals or other healthcare entities, (2) bundling its goods for exclusionary purposes, (3) conspiring with other manufacturers to impose rebate penalties on purchasers relating to the bundle of products.
A Settlement Fund consisting of $22 million in cash, plus interest has been established in this case.
Definition of Disposable Hypodermic Products Included in the Antitrust Settlement:
Products sold by BD in the following device categories:
- safety and conventional hypodermic needles and syringes;
- safety and conventional blood collection devices, including needles, blood collection tubes and tube holders;
- safety and conventional IV catheters, including winged IV catheters;
- safety and conventional insulin delivery devices.
Required Action Step:
Get Started by providing your details, then upon execution of our service agreement, CAC Recovery will file your claims and assist you in gathering the specific documentation necessary to maximize your Disposable Hypodermic Products Settlement recovery.
Our Class Action Settlement Services:
CAC Recovery navigates the complex intricacies of the Hypodermic Products Antitrust Settlement claims filing process to help businesses maximize their settlement recoveries.
Our class action settlement services include:
- Identifying class action claims where businesses may be eligible to file
- Filing the class action claim with supporting documentation
- Interacting with the class action Claims Administrator
- Providing updates on class action claim settlements status
- Resolving Claims Administrator questions on claims
- Reviewing the recovery to assure the correct compensation claims amount has been received
Our Guarantee: We Get Paid When You Recover – No hidden charges or up-front fees. We provide our class action settlements services based on a contingency fee.
Getting Started is easy! We’ll first have you fill out our ‘Get Started‘ form and a CAC representative will contact you within 24 hours to review your eligibility and walk you through the claims process.
The Direct Hypodermic Products Antitrust Settlement Filing Deadline Has Past
Direct – History
This notice applies to individuals or entities that purchased “Disposable Hypodermic Products” (as defined below) directly from Becton Dickinson & Co. (the “Defendant”) in the United States at any time during the period of March 23, 2001 through April 27, 2009 and were invoiced by the Defendant for such purchases. Purchases of disposable hypodermic products by you or your business on or after March 23, 2001, can make you eligible for the Hypodermic Products Settlement.
Direct – History
Several lawsuits were filed alleging the Defendant was unreasonably restraining trade and otherwise foreclosing competition through anticompetitive and illegal actions in the Disposable Hypodermic Products market almost eight (8) years ago. The matter was consolidated in the District of New Jersey and the plaintiffs in this case were divided into two (2) categories: distributors and health-care providers. The initial Hypodermic Products Settlement was agreed upon in 2009 between the Defendant and the distributor plaintiffs. The settlement was then delayed when a dispute arose amongst the plaintiffs as to which group qualified as “direct purchasers” under the Disposable Hypodermic Products Settlement. The court ruled that the health-care provider plaintiffs, not the distributors, were the direct purchasers, and thus entitled to settlement proceeds. On appeal, the U.S. Court of Appeals for the Third Circuit reversed this decision recently and ruled that the distributor plaintiffs are indeed the direct purchasers. At this point, the 2009 settlement agreement can be finalized. There is a fairness hearing scheduled for March 2013 where the court will determine whether to grant such final approval.
Direct – History
“Disposable Hypodermic Products” include (a) disposable syringes and associated needles; (b) disposable blood collection tubes; (c) disposable blood collection tube holders; and (d) intravenous (“IV”) catheter devices and their associated needles.